Nanomedicine Market Size & Share 2023 to 2032
Market Size by Modality (Treatment, Diagnostics), Application (Drug Delivery, IVD, Implant, Vaccine), Indication (Oncology, Infectious, Cardiovascular, Neurological), Molecule (Nanoparticle, Nanotube, Nanodevice), Global Forecast.
Report ID: GMI5909
|
Published Date: June 2023
|
Report Format: PDF
Download Free PDF
Authors:
Mariam Faizullabhoy, Gauri Wani
Nanomedicine Market Size
Nanomedicine Market size is predicted to grow at a (CAGR) of 11% from 2023 to 2032, with a value of USD 210.3 million in 2022. Significant advancements and the recent commercialization of technologies such as mRNA and liposome-based vaccines are projected to propel the expansion of nanomedicines in the coming years. In addition, the growing prevalence of nanotechnology-based pharmaceutical drug delivery technologies, as well as the widespread inefficiency of traditional therapies, offer potential growth opportunities for the nanomedicine business.
Nanomedicine Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Nanomedicine has the potential to transform the way diseases are treated. Nanoparticles can be utilised to deliver medications to tumours with better accuracy, reducing adverse effects and improving therapeutic success. Nanoparticles can potentially be utilised to transfer genes to cells for the treatment of genetic diseases.
The nanomedicine market is currently in its early phases of development, but it is anticipated to increase significantly in the future years. Several factors are contributing the development of novel nanomedicines, including the increased prevalence of chronic diseases, the rising expense of medication research, and the desire for precision medicine.
COVID-19 Impact
The COVID-19 pandemic had a significant impact on the nanomedicine market. In the short term, the pandemic has led to a decrease in research and development spending, as well as a disruption in supply chains. However, in the long term, the pandemic has driven growth in the market, as there is a growing demand for new and innovative treatments for COVID-19 and other diseases.
Moreover, nanomedicine is a rapidly growing field that uses nanotechnology to develop new treatments for diseases. Nanoparticles can be used to deliver drugs more effectively to target cells, and they can also be used to diagnose diseases at an earlier stage. Nanomedicine has the potential to revolutionize the way we treat diseases, and the COVID-19 pandemic has accelerated the development of new nanomedicine products.
Nanomedicine Market Trends
The market is experiencing several key trends that are shaping its development and driving innovation. Some of the prominent trends in the field include increasing focus on personalized medicine, advancements in drug delivery systems, growing application in oncology, emergence of nanosensors and diagnostics, integration of nanotechnology with other fields, and expansion of nanomedicine applications beyond healthcare. These trends indicate a promising future for the market and is expected to witness significant growth and transformative impact on healthcare and other industries.
Nanomedicine Market Analysis
Based on modality, the market is segmented as treatment and diagnostics. In 2022, the treatment segment accounted for the majority of the nanomedicine market size and is expected to grow at the fastest rate throughout the forecast period. One of the key drivers for this segment is the potential for enhanced therapeutic efficacy. Nanomedicine offers unique opportunities to improve the delivery of drugs and therapeutic agents to target sites within the body, resulting in more effective treatments.
In addition, nanomedicine enables targeted drug delivery, where therapeutic agents are encapsulated or attached to nanoparticles or nanocarriers. These nanoscale delivery systems can be designed to selectively target specific cells, tissues, or organs, allowing for precise drug delivery. This targeted approach enhances the therapeutic efficacy by concentrating the drug at the desired site and reducing its exposure to healthy cells, minimizing side effects.
Based on application, the nanomedicine market is segmented as drug delivery, in vitro diagnostics, implants, vaccines, in vivo imaging, and other applications. The drug delivery held a dominant market share of around 35.9% in 2022 and is expected to grow at a significant pace during the analysis period. Many drugs have limitations in terms of stability or solubility, which can affect their efficacy. Nanomedicine offers solutions to overcome these challenges by encapsulating drugs within nanoparticles or attaching them to nanocarriers. This encapsulation or attachment protects the drug from degradation and improves its solubility, ensuring better drug stability and bioavailability. This, in turn, enhances the drug's efficacy and allows for effective delivery to the target site.
Based on indication, the nanomedicine market is segmented as oncology, infectious diseases, cardiovascular diseases, orthopedic diseases, neurological diseases, and other indications. The oncology segment held a dominant market share in 2022 and is expected to grow at a significant pace of 11.5% between 2023 to 2032. This growth can be attributed to a number of factors, including increasing incidence of cancer, limited efficacy of conventional cancer therapies, advances in nanotechnology, and growing investment in nanomedicine research.
Conventional cancer therapies, such as chemotherapy and radiation therapy, can be effective in killing cancer cells. However, these therapies can also have significant side effects, such as nausea, vomiting, hair loss, and fatigue. Nanomedicine offers a potential solution to these problems, by delivering drugs directly to cancer cells, with minimal damage to healthy cells. This collectively contribute to the importance and growth of oncology segment.
Based on molecule type, the nanomedicine market is segmented as nanoparticles, nanotubes, nanodevices, and nanoshells. The nanoparticles segment is further divided into metal & metal oxide nanoparticles, liposomes, polymers & polymer drug conjugates, hydrogel nanoparticles, dendrimers, and inorganic nanoparticles. The nanoparticles segment held a dominant market share in 2022 and is expected to grow at a significant pace between 2023 to 2032. The large share of this segment can be attributed to its unique properties such as small size, large surface area, tailorable surface properties, drug delivery capabilities, imaging capabilities, versatility in functionalization, biocompatibility, and biodegradability. These characteristics make nanoparticles valuable tools for targeted drug delivery, imaging, and personalized medicine, offering significant potential for improving treatment outcomes in various diseases and advancing the field of nanomedicine.
North America nanomedicine market accounted for significant revenue in 2022 and is anticipated to grow at 11.3% during the forecast timeframe. North America has a well-defined regulatory framework for the approval and commercialization of medical products, including nanomedicine. Regulatory agencies, such as the Food and Drug Administration (FDA) in the U.S., have specific guidelines and processes in place to assess the safety and efficacy of nanomedicine products. The existence of a transparent and efficient regulatory environment enables companies to navigate the approval process and bring their nanomedicine products to market.
Nanomedicine Market Share
Some of the major market players operating in the nanomedicine market are:
These players focus on strategic partnerships, new application launch & commercialization for market expansion.
Nanomedicine Industry News:
The nanomedicine market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032, for the following segments:
Click here to Buy Section of this Report
By Modality, 2018 - 2032 (USD Million)
By Application, 2018 - 2032 (USD Million)
By Indication, 2018 - 2032 (USD Million)
By Molecule Type, 2018 - 2032 (USD Million)
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →